System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

FJ Blanco is an expert in Biochemistry at Complexo Hospitalario Universitario A Coruña (Spain). As of October 2026, ScienceLeadR ranks FJ Blanco in the top 1% of experts worldwide for Osteoarthritis and Arthritis. FJ Blanco has authored 404 publications, the most recent in 2026, and is an investigator in 29 clinical trials, 13 of them ongoing. SLR score: 1,909 (community average: 125). How the SLR is computed.

LeadR Profile

FJ Blanco Complexo Hospitalario Universitario A Coruña Spain
1 909 ScienceLeadR Reputation 1909

Unlock

Register Login
Network Map

Biochemistry

Subspecialties: Medical Imaging - Informatics - Rheumatology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1991 - 2026
Source: PubMed

Complexo Hospitalario Universitario A Coruña

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 404

Citations

Citations: 12 370 1st author: 27 Last author: 145 Unique author: 1

Main journals

Osteoarthritis Cartilage 176
Ann Rheum Dis 123
Eur J Biochem 5
J Mol Biol 5
Osteoarthritis imaging 5

Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
LONGITUDINAL CHANGES IN PERI-ARTICULAR BMD USING QUANTITATIVE CT IN KNEE OA PATIENTS: DATA FROM THE IMI-APPROACH STUDY.
PMID 42622183 — bone plates		Osteoarthr Imaging20260
How are patient-reported pain outcomes associated with biomarker and structural pathology subtypes in knee osteoarthritis? An explorative evaluation in the IMI-APPROACH cohort.
PMID 41531867 — osteoarthritis, knee, pain, meniscus, osteoarthritis, pathology, biomarkers, tissues, cartilage		Osteoarthr Cartil Open20250
Does spontaneous cartilage thickening occur in osteoarthritic knees? Data from IMI-APPROACH and the OAI.
PMID 41360179 — osteoarthritis, cartilage		Osteoarthritis Cartilage20250
Can gait patterns be explained by joint structure in people with and without radiographic knee osteoarthritis? Data from the IMI-APPROACH cohort.
PMID 38536417 — osteoarthritis, knee, osteoarthritis, gait, radiography, sex		Skeletal Radiol20247
AB0335 DIET ENRICHMENT WITH EXTRA VIRGIN OLIVE OIL INFLUENCES POSTURAL SYMMETRY AND EPIGENETIC REGULATION IN AN OSTEOARTHRITIS MURINE MODEL
OpenAlex W4401229802 — osteoarthritis, olive oil, diet		Ann Rheum Dis20240

Clinical Studies 29

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2 Study Chair: 1

By phase:

Phase 3 14
Phase 2 9
N/A 4
Phase 4 2

By status:

Completed 10
Active not recruiting 6
Recruiting 6
Terminated 4
Unknown 2
Not yet recruiting 1

By type:

Interventional 27
Observational 2

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 2
multicentricup10 26

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

13 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A study to learn about the efficacy and safety of 4P004 in participants with knee synovitis and osteoarthritis
2024-518916-38-00 — safety, osteoarthritis, therapeutics, synovitis		Phase 2Active not recruiting2025
Sarilumab efficacy and safety in adults with early polymyalgia rheumatica
2024-511296-15-00 — safety, prednisone, musculoskeletal diseases, polymyalgia rheumatica		Phase 3Recruiting2026
A study to investigate the efficacy and safety of subcutaneous sonelokimab versus placebo in participants aged 18 years and over with active psoriatic arthritis who are naive to biologic DMARDs
2024-516213-20-00 — arthritis, psoriatic, safety, arthritis, aged, therapeutics, female, male		Phase 3Active not recruiting2025
A Study of the Efficacy and Safety of JNJ 77242113 in Biologic experienced and Biologic na ve Participants with Active Psoriatic Arthritis
2024-517284-23-00 — arthritis, psoriatic, safety, arthritis, signs and symptoms, therapeutics		Phase 3Active not recruiting2025
SPY002 072 in Adults with Moderately to Severely Active Rheumatologic Disease
2025-521791-63-00 — safety, arthritis, axial spondyloarthritis		Phase 2Active not recruiting2025

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS